A bit of a discussion on X this morning, where a Steve (not having the best luck with them and stats debate on X) claimed that my correlating high dose uptake with more cases was flawed.
So I gave him some of the per-capita rate data we used to get until MoH squashed it.
He wanted that age-stratified because more old people get boosted and apparently, that makes a difference to him.
At this point, I became distracted by the fact we haven’t actually ever been able to break any of that down further.
Now, with the age-stratified Vaccine Rollout obtained via OIA, we can at least (because the others were never provided age AND dose stratified) do the stratification for the Deaths With Covid table. It’s somewhat interesting.
The 80+ 2-dose cohort was worst, then their Boosted, but their Not Fully Vaccinated group was a lot lower. I wonder if that was during that period where all those 80+ people who finally got dose 2 died within 29 days of the dose.
Next came the 65-79 2-dose cohort, their Not Fully Vaccinated next, then their Boosted. 65-79 is the only cohort that had Boosted fare best.
0-64 cohort saw a significantly smaller “with Covid” mortality rate. Their Boosted cohort was worst, then their NFV, then their Fully Vaccinated.
Now, of course, this is deaths (of any cause) where the person had tested positive for Covid within 4 weeks of death. When you’re getting vaccinated against a disease, I don’t think it’s overly useful when the people who take more than 3 doses of it die within 28 days of catching it.
The argument in favour of getting Boosted is weak, in my opinion.
